[HTML][HTML] Examining the role of the noradrenergic locus coeruleus for predicting attention and brain maintenance in healthy old age and disease: an MRI structural …
The noradrenergic theory of Cognitive Reserve (Robertson, 2013–2014) postulates that the
upregulation of the locus coeruleus—noradrenergic system (LC–NA) originating in the …
upregulation of the locus coeruleus—noradrenergic system (LC–NA) originating in the …
Neuropsychology and the dementia spectrum: Differential diagnosis, clinical management, and forensic utility
VL Begali - NeuroRehabilitation, 2020 - content.iospress.com
BACKGROUND: The utility of neuropsychology in the treatment and evaluation of
neuropsychological disorders and neurodegenerative diseases is supported by scientific …
neuropsychological disorders and neurodegenerative diseases is supported by scientific …
[PDF][PDF] Kognitiivisten toimintojen muutokset-mikä on ikääntymistä, mikä sairautta?
E Vuoksimaa - Duodecim, 2019 - researchportal.helsinki.fi
Kognitiivinen ikääntyminen kuuluu läpi elämän tapahtuviin muutoksiin muistissa ja muissa
tiedon käsittelyyn liittyvissä toiminnoissa. Monet kognition osaalueet alkavat heiketä jo …
tiedon käsittelyyn liittyvissä toiminnoissa. Monet kognition osaalueet alkavat heiketä jo …
Cognitive practice effects delay diagnosis of MCI: Implications for clinical trials
M Sanderson‐Cimino, JA Elman, XM Tu… - … Research & Clinical …, 2022 - Wiley Online Library
Abstract Introduction Practice effects (PEs) on cognitive tests obscure decline, thereby
delaying detection of mild cognitive impairment (MCI). Importantly, PEs may be present even …
delaying detection of mild cognitive impairment (MCI). Importantly, PEs may be present even …
[HTML][HTML] A pilot study of brain morphometry following donepezil treatment in mild cognitive impairment: volume changes of cortical/subcortical regions and …
GW Kim, BC Kim, KS Park, GW Jeong - Scientific reports, 2020 - nature.com
The efficacy of donepezil is well known for improving the cognitive performance in patients
with mild cognitive impairment (MCI) and Alzheimer's disease (AD). Most of the recent …
with mild cognitive impairment (MCI) and Alzheimer's disease (AD). Most of the recent …
[HTML][HTML] The use of episodic memory tests for screening in clinical trials for early Alzheimer's Disease: a comparison of the free and cued selective reminding test …
E Teng, PT Manser, M Shah, K Pickthorn, N Hu… - The Journal of …, 2023 - Springer
Background Screening procedures for early Alzheimer's disease (AD) trials seek to
efficiently identify participants who fulfill clinical and biomarker criteria for AD and enrich for …
efficiently identify participants who fulfill clinical and biomarker criteria for AD and enrich for …
Novel characterization of the relationship between verbal list‐learning outcomes and hippocampal subfields in healthy adults
The relationship between hippocampal subfield volumetry and verbal list‐learning test
outcomes have mostly been studied in clinical and elderly populations, and remain …
outcomes have mostly been studied in clinical and elderly populations, and remain …
[HTML][HTML] Neuroimage biomarker identification of the conversion of mild cognitive impairment to Alzheimer's Disease
An efficient method to identify whether mild cognitive impairment (MCI) has progressed to
Alzheimer's disease (AD) will be beneficial to patient care. Previous studies have shown that …
Alzheimer's disease (AD) will be beneficial to patient care. Previous studies have shown that …
Tsallis-entropy segmentation through MRF and Alzheimer anatomic reference for brain magnetic resonance parcellation
Quantifying the intracranial tissue volume changes in magnetic resonance imaging (MRI)
assists specialists to analyze the effects of natural or pathological changes. Since these …
assists specialists to analyze the effects of natural or pathological changes. Since these …
[HTML][HTML] Effects of APOE ε2 on the fractional amplitude of low-frequency fluctuation in mild cognitive impairment: a study based on the resting-state functional MRI
X Liu, Q Zeng, X Luo, K Li, H Hong, S Wang… - Frontiers in Aging …, 2021 - frontiersin.org
Background Apolipoprotein E (APOE) ε2 is a protective genetic factor for Alzheimer's
disease (AD). However, the potential interaction effects between the APOE ε2 allele and …
disease (AD). However, the potential interaction effects between the APOE ε2 allele and …